Prospective analysis of UGT1A1 genotyping for predicting toxicities in advanced colorectal cancer (aCRC) treated with irinotecan (IRI)-based regimens: Interim safety analysis of a Japanese observational study.
Wataru Ichikawa
Consultant or Advisory Role - Daiichi Sankyo (U)
Honoraria - Daiichi Sankyo
Keisuke Uehara
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Keisuke Minamimura
Research Funding - Daiichi Sankyo
Chihiro Tanaka
Research Funding - Daiichi Sankyo
Yasumasa Takii
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Sotaro Sadahiro
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Hideaki Miyauchi
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Katsunori Shinozaki
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Takuya Miyagaki
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Toshio Otsuji
Research Funding - Daiichi Sankyo
Takeshi Kambara
Research Funding - Daiichi Sankyo
Satoshi Morita
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Other Remuneration - Daiichi Sankyo
Yuichi Ando
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Other Remuneration - Daiichi Sankyo
Yukihiro Okutani
Employment or Leadership Position - Daiichi Sankyo
Stock Ownership - Daiichi Sankyo
Masahiro Sugihara
Employment or Leadership Position - Daiichi Sankyo
Toru Sugiyama
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Yasuo Ohashi
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Yuh Sakata
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo